Published Date: 21 Aug 2024
Researchers at the University of Reading have contributed to a study that could lead to new treatments for a deadly cancer caused by a herpesvirus.
Read Full NewsBacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...
Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.
Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...
1.
Chromatin organization linked to p53 tumor suppression mechanism
2.
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
3.
Cancer After Weight Loss; How Older Adults Use the Healthcare System.
4.
Patients face high out-of-pocket costs after incident cancer diagnosis
5.
In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.
1.
Breaking Down the Different Types of Lymphoma: What You Need to Know
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Glycopyrrolate: The Secret Weapon for Excessive Sweating
4.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
5.
Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation